Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

Emma Walmsley, CEO, GSK discusses how a global business is managing today's volatile economic and regulatory environment with ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

(Reuters) -British drugmaker GSK said on Monday Emma Walmsley will step down as CEO after nine years at the helm and will be ...

Emma Walmsley has overseen eight turbulent years at he U.K. drugmaker. The firm announced Monday that she will be succeeded ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top ...

GSK CEO Dame Emma Walmsley will step down at the end of 2025 and be succeeded by Luke Miels, who will lead the company into a ...